Hybrid compounds demonstrate strong anticancer effects in triple-negative breast cancer cells, implying potential as therapeutic agents.
A series of 1H-1,2,3-triazole-tethered TCS–isatin hybrid compounds were synthesized and evaluated for their antiproliferative activity against triple-negative breast cancer (TNBC). These hybrids exhibited remarkable potency against MDA-MB-231 and MDA-MB-468 cell...
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: